首页> 美国卫生研究院文献>Materials >Carboxylic Terminated Thermo-Responsive Copolymer Hydrogel and Improvement in Peptide Release Profile
【2h】

Carboxylic Terminated Thermo-Responsive Copolymer Hydrogel and Improvement in Peptide Release Profile

机译:羧酸封端的热响应共聚物水凝胶和肽释放曲线的改进

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To improve the release profile of peptide drugs, thermos-responsive triblock copolymer poly (ε-caprolactone-co-p-dioxanone)-b-poly (ethylene glycol)-b-poly (ε-caprolactone-co-p-dioxanone) (PECP) was prepared and end capped by succinic anhydride to give its carboxylic terminated derivative. Both PCEP block copolymer and its end group modified derivative showed temperature-dependent reversible sol-gel transition in water. The carboxylic end group could significantly decrease the sol-gel transition temperature by nearly 10 °C and strengthen the gel due to enhanced intermolecular force among triblock copolymer chains. Furthermore, compared with the original PECP triblock copolymer, HOOC–PECP–COOH copolymer displayed a retarded and sustained release profile for leuprorelin acetate over one month while effectively avoiding the initial burst. The controlled release was believed to be related to the formation of conjugated copolymer-peptide pair by ionic interaction and enhanced solubility of drug molecules into the hydrophobic domains of the hydrogel. Therefore, carboxyl terminated HOOC–PECP–COOH hydrogel was a promising and well-exhibited sustained release carrier for peptide drugs with the advantage of being able to develop injectable formulation by simple mixing.
机译:为了改善肽药物的释放特性,热响应三嵌段共聚物聚(ε-己内酯-共-对二恶烷酮)-b-聚(乙二醇)-b-聚(ε-己内酯-共-对二恶烷酮)(制备PECP)并用琥珀酸酐封端以得到其羧基封端的衍生物。 PCEP嵌段共聚物及其端基修饰的衍生物均在水中显示出温度依赖性的可逆溶胶-凝胶转变。由于三嵌段共聚物链之间的分子间力增加,羧基端基可将溶胶-凝胶转变温度显着降低近10°C,并增强凝胶。此外,与原始的PECP三嵌段共聚物相比,HOOC-PECP-COOH共聚物在一个月的时间内显示出醋酸亮丙瑞林的缓释和持续释放特性,同时有效避免了初次爆裂。据信控释与通过离子相互作用形成共轭共聚物-肽对和药物分子在水凝胶的疏水域中的增加的溶解度有关。因此,羧基封端的HOOC-PECP-COOH水凝胶是一种有前途且表现良好的肽药物缓释载体,其优势在于能够通过简单的混合来开发注射剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号